Synlait Milk says that it expects strong global demand for its lactoferrin to continue since it began commercially producing and selling the valuable milk protein earlier this year.
Managing director Dr John Penno said the response from customers about the performance of Synlait Milk’s lactoferrin in their product applications has been very positive.
“Our initial focus on its application in infant formula and over the counter nutraceutical products such as health tablets is paying off.,” he said. “Globally, consumers are increasingly looking for nutritious and safe food that contributes to the long-term health and well-being of their families. Lactoferrin can help meet these needs.”
Used in the manufacture of infant formula, health food and pharmaceutical products, the bioactive protein is said to provide significant anti-inflammatory protection and other health benefits.
“It is an important step forward for the business,” continued Penno. “We have had interest for some time from customers looking to enhance the performance of lactoferrin as an ingredient in their infant formula products. By producing spray-dried lactoferrin, through a process which has been designed to protect its bio-activity and increase solubility, we are able to meet their needs.”
Following the upgrade of its Specialty Milks Dryer earlier this year, Synlait Milk says that it became one of only two manufacturers world-wide with the capability to produce lactoferrin as a spray-dried powder.
According to the company, the market for lactoferrin has grown from 45,000 kgs in 2001 to 185,000 kgs in 2012 and is projected to grow to 262,000 kgs in 2017. Synlait Milk is targeting sales of 15 metric tonnes of lactoferrin in the current financial year.
